{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:34:39Z","timestamp":1792708479825,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["U54TR002823"],"award-info":[{"award-number":["U54TR002823"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ymgme.2024.108453","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T12:44:17Z","timestamp":1710765857000},"page":"108453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Longitudinal natural history studies based on real-world data in rare diseases: Opportunity and a novel approach"],"prefix":"10.1016","volume":"142","author":[{"given":"Laura Ann","family":"Adang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Sevagamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Sherbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Bonkowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Gavazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel","family":"D'Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholson B.","family":"Modesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Mutua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Kotes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Shults","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa T.","family":"Emrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith P.","family":"Van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Woidill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Barcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Pizzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna L.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Vanderver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgme.2024.108453_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002191","article-title":"What is the purpose of the orphan drug act?","volume":"14","author":"Herder","year":"2017","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108453_bb0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/d41573-019-00180-y","article-title":"How many rare diseases are there?","volume":"19","author":"Haendel","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108453_bb0015","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jdv.17165","article-title":"Epidemiology of rare diseases is important","volume":"35","author":"Bruckner-Tuderman","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108453_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"Nguengang Wakap","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108453_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13073-022-01026-w","article-title":"A guide for the diagnosis of rare and undiagnosed disease: beyond the exome","volume":"14","author":"Marwaha","year":"2022","journal-title":"Genome Med."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108453_bb0030","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/s41436-021-01241-7","article-title":"Can you hear us now? The impact of health-care utilization by rare disease patients in the United States","volume":"23","author":"Navarrete-Opazo","year":"2021","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108453_bb0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjd.21686","article-title":"The challenges of clinical trials in rare diseases","volume":"187","author":"Mellerio","year":"2022","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108453_bb0040","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1373\/clinchem.2009.141622","article-title":"Newborn screening of lysosomal storage disorders","volume":"56","author":"Marsden","year":"2010","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108453_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1542\/pir.2019-0184","article-title":"Early signs and symptoms of Leukodystrophies: a case-based guide","volume":"42","author":"Ruzhnikov","year":"2021","journal-title":"Pediatr. Rev."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108453_bb0050","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-053126","article-title":"Leukodystrophies in children: diagnosis, care, and treatment","volume":"148","author":"Bonkowsky","year":"2021","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108453_bb0055","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ajmg.a.38413","article-title":"Challenges of developing and conducting clinical trials in rare disorders","volume":"176","author":"Kempf","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2024.108453_bb0060","doi-asserted-by":"crossref","first-page":"1098454","DOI":"10.3389\/fneur.2023.1098454","article-title":"Study design challenges and strategies in clinical trials for rare diseases: lessons learned from pantothenate kinase-associated neurodegeneration","volume":"14","author":"Videnovic","year":"2023","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108453_bb0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.pcl.2015.03.006","article-title":"Emerging treatments for pediatric leukodystrophies","volume":"62","author":"Helman","year":"2015","journal-title":"Pediatr. Clin. N. Am."},{"issue":"S2","key":"10.1016\/j.ymgme.2024.108453_bb0070","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/jcph.2134","article-title":"Natural history and real-world data in rare diseases: applications, limitations, and future perspectives","volume":"62","author":"Liu","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ymgme.2024.108453_bb0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1756-0500-7-264","article-title":"The clinical case report: a review of its merits and limitations","volume":"7","author":"Nissen","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.ymgme.2024.108453_bb0080","author":"theglia.org"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108453_bb0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/0929867324666170718101946","article-title":"NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment","volume":"25","author":"Fernandez-Marmiesse","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ymgme.2024.108453_bb0090","doi-asserted-by":"crossref","first-page":"1249585","DOI":"10.3389\/fgene.2023.1249585","article-title":"Editorial: next generation sequencing (NGS) for rare diseases diagnosis - volume II","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2024.108453_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.61641","article-title":"Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing","author":"Schmidt","year":"2020","journal-title":"Am. J. Med. Genet. A"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108453_bb0100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0036-1588020","article-title":"Update on Leukodystrophies: a historical perspective and adapted definition","volume":"47","author":"Kevelam","year":"2016","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2024.108453_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25757","article-title":"Randomized clinical trial of first-line genome sequencing in pediatric white matter disorders","author":"Vanderver","year":"2020","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108453_bb0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","article-title":"Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms","volume":"134","author":"van der Knaap","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2024.108453_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2020.10.012","article-title":"Late-onset Aicardi-Gouti\u00e8res syndrome: a characterization of presenting clinical features","volume":"115","author":"Piccoli","year":"2021","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108453_bb0120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/jnnp-2018-319481","article-title":"Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era","volume":"90","author":"Lynch","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2024.108453_bb0125","doi-asserted-by":"crossref","first-page":"107678","DOI":"10.1016\/j.ymgme.2023.107678","article-title":"VUS: Variant of uncertain significance or very unclear situation?","author":"Kemp","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"6148","key":"10.1016\/j.ymgme.2024.108453_bb0130","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"issue":"10043","key":"10.1016\/j.ymgme.2024.108453_bb0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: An ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"vol. 388","author":"Sessa","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108453_bb0140","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/sctm.19-0304","article-title":"Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy","volume":"9","author":"Gupta","year":"2020","journal-title":"Stem Cells Transl. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108453_bb0145","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbmt.2018.09.036","article-title":"Survival and functional outcomes in boys with cerebral Adrenoleukodystrophy with and without hematopoietic stem cell transplantation","volume":"25","author":"Raymond","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"13","key":"10.1016\/j.ymgme.2024.108453_bb0150","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1212\/WNL.0000000000004418","article-title":"Developmental outcomes of cord blood transplantation for Krabbe disease: a 15-year study","volume":"89","author":"Wright","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2024.108453_bb0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13023-015-0313-y","article-title":"Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report","volume":"10","author":"Boucher","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108453_bb0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MED.0000000000000515","article-title":"Adrenoleukodystrophy in the era of newborn screening","volume":"27","author":"Eng","year":"2020","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108453_bb0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jdn.10003","article-title":"X-linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies","volume":"80","author":"Turk","year":"2020","journal-title":"Int. J. Dev. Neurosci."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108453_bb0170","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1021\/acs.analchem.9b05274","article-title":"Leukocyte and dried blood spot arylsulfatase a assay by tandem mass spectrometry","volume":"92","author":"Hong","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2024.108453_bb0175","article-title":"MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines","author":"Mallack","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108453_bb0180","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ajmg.a.61171","article-title":"A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy","volume":"179","author":"Wiens","year":"2019","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2024.108453_bb0185","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad286","article-title":"Early detection of adrenal insufficiency: the impact of newborn screening for Adrenoleukodystrophy","author":"Ramirez Alcantara","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108453_bb0190","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13023-020-01659-3","article-title":"The natural history of Canavan disease: 23 new cases and comparison with patients from literature","volume":"16","author":"Bley","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108453_bb0195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13023-020-01489-3","article-title":"Natural history of Krabbe disease - a nationwide study in Germany using clinical and MRI data","volume":"15","author":"Krieg","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108453_bb0200","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jimd.12388","article-title":"Metachromatic leukodystrophy: a single-center longitudinal study of 45 patients","volume":"44","author":"Fumagalli","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108453_bb0205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-018-0872-9","article-title":"A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life","volume":"13","author":"Bascou","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2024.108453_bb0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2014.12.023","article-title":"Modeling the natural history of Pelizaeus-Merzbacher disease","volume":"75","author":"Mayer","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108453_bb0215","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1212\/WNL.0000000000200571","article-title":"Presymptomatic lesion in childhood cerebral Adrenoleukodystrophy: timing and treatment","volume":"99","author":"Mallack","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108453_bb0220","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4338\/ACI-2013-12-RA-0105","article-title":"A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records","volume":"5","author":"Weng","year":"2014","journal-title":"Appl. Clin. Inform."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108453_bb0225","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1007\/s00415-020-10374-9","article-title":"Metachromatic leukodystrophy with late adult-onset: diagnostic clues and differences from other genetic leukoencephalopathies with dementia","volume":"268","author":"Benzoni","year":"2021","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108453_bb0230","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/ene.12423","article-title":"Leukodystrophies underlying cryptic spastic paraparesis: frequency and phenotype in 76 patients","volume":"21","author":"M\u00fcller vom Hagen","year":"2014","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108453_bb0235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaac.2017.11.017","article-title":"Slowly progressive psychiatric symptoms: think metachromatic Leukodystrophy","volume":"57","author":"van Rappard","year":"2018","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108453_bb0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0883073819870944","article-title":"Developmental outcomes of Aicardi Gouti\u00e8res syndrome","volume":"35","author":"Adang","year":"2020","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2024.108453_bb0245","doi-asserted-by":"crossref","DOI":"10.1177\/0883073821000977","article-title":"Acquisition of Developmental Milestones in Hypomyelination With Atrophy of the Basal Ganglia and Cerebellum and Other TUBB4A-Related Leukoencephalopathy","author":"Gavazzi","year":"2021","journal-title":"J. Child Neurol."},{"issue":"17","key":"10.1016\/j.ymgme.2024.108453_bb0250","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic stem-cell gene therapy for cerebral Adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10322","key":"10.1016\/j.ymgme.2024.108453_bb0255","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2024.108453_bb0260","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pediatrneurol.2020.03.005","article-title":"Phenotypic and imaging Spectrum associated with WDR45","volume":"109","author":"Adang","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2024.108453_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12298","article-title":"Natural history of multiple sulfatase deficiency: retrospective phenotyping and functional variant analysis to characterize an ultra-rare disease","author":"Adang","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2024.108453_bb0270","article-title":"An introduction to ICD code development for pediatric neurology","author":"Baker","year":"2024","journal-title":"Ann. Child Neurol. Soc."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108453_bb0275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12874-023-01972-y","article-title":"Frequency-based rare diagnoses as a novel and accessible approach for studying rare diseases in large datasets: a cross-sectional study","volume":"23","author":"Tr\u00f6ster","year":"2023","journal-title":"BMC Med. Res. Methodol."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108453_bb0280","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/ije\/dyq139","article-title":"Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies","volume":"39","author":"Fortier","year":"2010","journal-title":"Int. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108453_bb0285","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/ije\/dyr106","article-title":"Is rigorous retrospective harmonization possible? Application of the DataSHaPER approach across 53 large studies","volume":"40","author":"Fortier","year":"2011","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108453_bb0290","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1017\/cts.2020.24","article-title":"Guidelines for Data Acquisition, Quality and Curation for Observational Research Designs (DAQCORD)","volume":"4","author":"Ercole","year":"2020","journal-title":"J. Clin. Transl. Sci."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108453_bb0295","first-page":"172","article-title":"Standard operating procedures for clinical research departments","volume":"27","author":"Kee","year":"2011","journal-title":"J. Med. Pract. Manage"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108453_bb0300","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/2229-3485.140555","article-title":"Basics of case report form designing in clinical research","volume":"5","author":"Bellary","year":"2014","journal-title":"Perspect. Clin. Res."},{"key":"10.1016\/j.ymgme.2024.108453_bb0305","article-title":"Hepatic involvement in Aicardi-Gouti\u00e8res syndrome","author":"Gavazzi","year":"2021","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108453_bb0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2020.03.008","article-title":"Development of a neurologic severity scale for Aicardi Gouti\u00e8res syndrome","volume":"130","author":"Adang","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108453_bb0315","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1056\/NEJMc2001362","article-title":"Janus kinase inhibition in the Aicardi-Gouti\u00e8res syndrome","volume":"383","author":"Vanderver","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2024.108453_bb0320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1172-9-18","article-title":"Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort","volume":"9","author":"Kehrer","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108453_bb0325","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1469-8749.2010.03821.x","article-title":"Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy","volume":"53","author":"Kehrer","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108453_bb0330","article-title":"Overview of Four Functional Classification Systems Commonly Used in Cerebral Palsy","volume":"4","author":"Paulson","year":"2017","journal-title":"Children (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.ymgme.2024.108453_bb0335","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ymgme.2022.06.003","article-title":"Hematologic abnormalities in Aicardi Goutieres syndrome","volume":"136","author":"Adang","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108453_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103448","article-title":"Multiple sulfatase deficiency: a disease comprising Mucopolysaccharidosis, Sphingolipidosis, and more caused by a defect in posttranslational modification","volume":"21","author":"Schlotawa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108453_bb0345","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ymgme.2022.02.006","article-title":"Early developmental delay in Leigh syndrome spectrum disorders is associated with poor clinical prognosis","volume":"135","author":"Tinker","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108453_bb0350","article-title":"Developmental outcomes of Aicardi Gouti\u00e8res syndrome","author":"Adang","year":"2019","journal-title":"J. Child Neurol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224002683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224002683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T12:16:17Z","timestamp":1735215377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224002683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1096719224002683"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108453","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal natural history studies based on real-world data in rare diseases: Opportunity and a novel approach","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108453"}}